Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ioannis Avgerinos, Panagiota Kakotrichi, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas. (2024) The preclinical discovery and clinical evaluation of tirzepatide for the treatment of type 2 diabetes. Expert Opinion on Drug Discovery 19:5, pages 511-522.
Read now
Read now
Naciye Isbil-Buyukcoskun, Betul Cam, Guldal Gulec Suyen & Kasim Ozluk. (2018) Effects of intracerebroventricularly injected glucagon-like peptide-2 on ethanol-induced gastric mucosal damage in rats. Endocrine Research 43:4, pages 220-227.
Read now
Read now
David W. Lim, Paul W. Wales, Justine M. Turner, David L. Bigam & Patricia L. Brubaker. (2016) On the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndrome. Expert Opinion on Therapeutic Targets 20:7, pages 819-830.
Read now
Read now
Cheng T Tee, Katharina Wallis & Simon M Gabe. (2011) Emerging treatment options for short bowel syndrome: potential role of teduglutide. Clinical and Experimental Gastroenterology 4, pages 189-196.
Read now
Read now
Kishore Vipperla & Stephen J O’Keefe. (2011) Teduglutide for the treatment of short bowel syndrome. Expert Review of Gastroenterology & Hepatology 5:6, pages 665-678.
Read now
Read now
Pamela J Hornby & Beverley A Moore. (2011) The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease. Expert Opinion on Therapeutic Targets 15:5, pages 637-646.
Read now
Read now
Amaya Aleixandre & Marta Miguel. (2008) Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review. Critical Reviews in Food Science and Nutrition 48:10, pages 905-912.
Read now
Read now
Carl Frederic Nagell, Jan F. Pedersen & Jens J. Holst. (2007) The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man. Scandinavian Journal of Gastroenterology 42:1, pages 28-33.
Read now
Read now
Carl Frederik Nagell, André Wettergren, Cathrine Ørskov & Jens Juul Holst. (2006) Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs. Scandinavian Journal of Gastroenterology 41:6, pages 667-672.
Read now
Read now
Articles from other publishers (72)
Thorir G. Pálsson, Hannah Gilliam-Vigh, Benjamin A.H. Jensen, Palle B. Jeppesen, Asger B. Lund, Filip K. Knop & Casper K. Nielsen. (2024) Targeting the GLP-2 receptor in the management of obesity. Peptides 177, pages 171210.
Crossref
Crossref
Kundanika Mukherjee & Changting Xiao. (2024) GLP-2 regulation of intestinal lipid handling. Frontiers in Physiology 15.
Crossref
Crossref
Daniel J. Drucker & Jens J. Holst. (2023) The expanding incretin universe: from basic biology to clinical translation. Diabetologia 66:10, pages 1765-1779.
Crossref
Crossref
Jihwan Lee & Woo Kyun Kim. (2023) Applications of Enteroendocrine Cells (EECs) Hormone: Applicability on Feed Intake and Nutrient Absorption in Chickens. Animals 13:18, pages 2975.
Crossref
Crossref
Maria Buur Nordskov Gabe, Liv von Voss, Jenna Elizabeth Hunt, Sarina Gadgaard, Lærke Smidt Gasbjerg, Jens Juul Holst, Hannelouise Kissow, Bolette Hartmann & Mette Marie Rosenkilde. (2023) Biased GLP‐2 agonist with strong G protein‐coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice. British Journal of Pharmacology 180:13, pages 1674-1689.
Crossref
Crossref
Astrid Verbiest, Palle Bekker Jeppesen, Francisca Joly & Tim Vanuytsel. (2023) The Role of a Colon-in-Continuity in Short Bowel Syndrome. Nutrients 15:3, pages 628.
Crossref
Crossref
Julie Bines, Jason Yap, Kelly Tappenden & Jeremy M. D. Nightingale. 2023. Intestinal Failure. Intestinal Failure
435
449
.
Astrid Verbiest, Lucas Wauters & Tim Vanuytsel. (2022) Enterohormone therapy for short bowel syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 29:2, pages 207-218.
Crossref
Crossref
Lizeth Cifuentes & Andres Acosta. (2022) Homeostatic regulation of food intake. Clinics and Research in Hepatology and Gastroenterology 46:2, pages 101794.
Crossref
Crossref
Russell D. Dolan, Tameh S. Rohani, Divya Muttineni & Hiroshi Mashimo. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
2
56
.
Huiling Sun, Kai Meng, Lin Hou, Lijun Shang & Jianqun Yan. (2021) Melanocortin receptor-4 mediates the anorectic effect induced by the nucleus tractus solitarius injection of glucagon-like Peptide-2 in fasted rats. European Journal of Pharmacology 901, pages 174072.
Crossref
Crossref
Jacek Sobocki, Zuzanna Zaczek, Paulina Jurczak, Karolina Lachowicz, Marek Kunecki, Patrycja Groszek, Krystyna Majewska, Mariusz Panczyk & Alastair Forbes. (2020)
Restricted
v
. unrestricted oral intake in high output end-jejunostomy patients referred to reconstructive surgery
. British Journal of Nutrition 125:10, pages 1125-1131.
Crossref
Crossref
Lizeth Cifuentes, Michael Camilleri & Andres Acosta. (2021) Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity—Therapeutic Implications. Nutrients 13:4, pages 1158.
Crossref
Crossref
Nina L. HansenAndreas BrøndenChristina C. Nexøe-LarsenAlexander S. ChristensenDavid P. SonneJens F. RehfeldNicolai J. Wever AlbretchsenBolette HartmannTina VilsbøllJens J. HolstFilip K. Knop. (2020) Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study. Clinical and Translational Gastroenterology 11:12, pages e00257.
Crossref
Crossref
Malcolm J. Borg, Christopher K. Rayner, Karen L. Jones, Michael Horowitz, Cong Xie & Tongzhi Wu. (2020) Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin. Pharmaceuticals 13:11, pages 410.
Crossref
Crossref
Koji Maruta, Takeshi Takajo, Yasutada Akiba, Hyder Said, Emi Irie, Ikuo Kato, Atsukazu Kuwahara & Jonathan D. Kaunitz. (2020) GLP-2 Acutely Prevents Endotoxin-Related Increased Intestinal Paracellular Permeability in Rats. Digestive Diseases and Sciences 65:9, pages 2605-2618.
Crossref
Crossref
Palle Bekker Jeppesen, Simon M. Gabe, Douglas L. Seidner, Hak-Myung Lee & Clément Olivier. (2020) Citrulline correlations in short bowel syndrome–intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study. Clinical Nutrition 39:8, pages 2479-2486.
Crossref
Crossref
Chiara Traini, Eglantina Idrizaj, Rachele Garella, Roberta Squecco, Maria Giuliana Vannucchi & Maria Caterina Baccari. (2020) Glucagon-like peptide-2 interferes with the neurally-induced relaxant responses in the mouse gastric strips through VIP release. Neuropeptides 81, pages 102031.
Crossref
Crossref
Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston, Régent Laporte, Steve Qi, Karthik Srinivasan, Javier Sueiras-Diaz, Kazimierz Wiśniewski, Jennifer Hartwig, Mark Lu, Alexander P. Posch, Halina Wiśniewska, Claudio D. Schteingart, Pierre J.-M. Rivière & Violetta Dimitriadou. (2020) Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. Journal of Pharmacology and Experimental Therapeutics 373:2, pages 193-203.
Crossref
Crossref
Jia Jiet Lim & Sally D. Poppitt. (2019) How Satiating Are the ‘Satiety’ Peptides: A Problem of Pharmacology versus Physiology in the Development of Novel Foods for Regulation of Food Intake. Nutrients 11:7, pages 1517.
Crossref
Crossref
Michael Camilleri. (2019) Gastrointestinal hormones and regulation of gastric emptying. Current Opinion in Endocrinology, Diabetes & Obesity 26:1, pages 3-10.
Crossref
Crossref
Alan L. Buchman. (2018) Intestinal Failure and Rehabilitation. Gastroenterology Clinics of North America 47:2, pages 327-340.
Crossref
Crossref
Georgios K. Dimitriadis & Alexander D. Miras. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
561
564
.
Christine Emilien & James H. Hollis. (2017) A brief review of salient factors influencing adult eating behaviour. Nutrition Research Reviews 30:2, pages 233-246.
Crossref
Crossref
Rachele Garella, Eglantina Idrizaj, Chiara Traini, Roberta Squecco, Maria Giuliana Vannucchi & Maria Caterina Baccari. (2017) Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus. World Journal of Gastroenterology 23:40, pages 7211-7220.
Crossref
Crossref
Pernille Wismann, Pernille Barkholt, Thomas Secher, Niels Vrang, Henrik B. Hansen, Palle Bekker Jeppesen, Laurie L. Baggio, Jacqueline A. Koehler, Daniel J. Drucker, Darleen A. Sandoval & Jacob Jelsing. (2017) The endogenous preproglucagon system is not essential for gut growth homeostasis in mice. Molecular Metabolism 6:7, pages 681-692.
Crossref
Crossref
Sara Baldassano, Antonella Amato & Flavia Mulè. (2016) Influence of glucagon-like peptide 2 on energy homeostasis. Peptides 86, pages 1-5.
Crossref
Crossref
Johanna Iturrino, Michael Camilleri, Andres Acosta, Jessica O'Neill, Duane Burton, Jithinraj Edakkanambeth Varayil, Paula J. Carlson, Alan R. Zinsmeister & Ryan Hurt. (2015) Acute Effects of a Glucagon‐Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition 40:8, pages 1089-1095.
Crossref
Crossref
Kazimierz Wiśniewski, Javier Sueiras-Diaz, Guangcheng Jiang, Robert Galyean, Mark Lu, Dorain Thompson, Yung-Chih Wang, Glenn Croston, Alexander Posch, Diane M. Hargrove, Halina Wiśniewska, Régent Laporte, John J. Dwyer, Steve Qi, Karthik Srinivasan, Jennifer Hartwig, Nicky Ferdyan, Monica Mares, John Kraus, Sudarkodi Alagarsamy, Pierre J. M. Rivière & Claudio D. Schteingart. (2016) Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance. Journal of Medicinal Chemistry 59:7, pages 3129-3139.
Crossref
Crossref
Mei Kei Yong, Vicky A. Solah, Stuart K. Johnson, Xingqiong Meng, Deborah A. Kerr, Anthony P. James, Haelee K. Fenton, Roland J. Gahler & Simon Wood. (2016) Effects of a viscous-fibre supplemented evening meal and the following un-supplemented breakfast on post-prandial satiety responses in healthy women. Physiology & Behavior 154, pages 34-39.
Crossref
Crossref
Brian Finan, Christoffer Clemmensen & Timo D. Müller. (2015) Emerging opportunities for the treatment of metabolic diseases: Glucagon-like peptide-1 based multi-agonists. Molecular and Cellular Endocrinology 418, pages 42-54.
Crossref
Crossref
Sara Baldassano, Francesca Rappa, Antonella Amato, Francesco Cappello & Flavia Mulè. (2015) GLP‐2 as Beneficial Factor in the Glucose Homeostasis in Mice Fed a High Fat Diet. Journal of Cellular Physiology 230:12, pages 3029-3036.
Crossref
Crossref
Changting Xiao, Satya Dash, Cecilia Morgantini, Khosrow Adeli & Gary F. Lewis. (2015) Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism. Diabetes 64:7, pages 2310-2318.
Crossref
Crossref
Hannelouise Kissow. (2015) Glucagon-like peptides 1 and 2. Current Opinion in Supportive & Palliative Care 9:2, pages 196-202.
Crossref
Crossref
E. E. Connor, C. M. Evock-Clover, M. P. Walker, T. H. Elsasser & S. Kahl. (2015) COMPARATIVE GUT PHYSIOLOGY SYMPOSIUM: Comparative physiology of glucagon-like peptide-2: Implications and applications for production and health of ruminants12. Journal of Animal Science 93:2, pages 492-501.
Crossref
Crossref
Guldal Gulec Suyen, Naciye Isbil-Buyukcoskun, Betul Cam & Kasim Ozluk. (2015) Effects of centrally injected glucagon-like peptide-2 on gastric mucosal blood flow in rats: Possible mechanisms. Peptides 64, pages 62-66.
Crossref
Crossref
Jolene Kay Berg, Eric H Kim, Benjamin Li, Bo Joelsson & Nader N Youssef. (2014) A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects. BMC Gastroenterology 14:1.
Crossref
Crossref
Sara Baldassano & Antonella Amato. (2014) GLP-2: What do we know? What are we going to discover?. Regulatory Peptides 194-195, pages 6-10.
Crossref
Crossref
Xinfu Guan. (2014) The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307:6, pages R585-R596.
Crossref
Crossref
Kelly A. Tappenden. (2014) Pathophysiology of Short Bowel Syndrome. Journal of Parenteral and Enteral Nutrition 38:1S.
Crossref
Crossref
Kim T. Nguyen & Judith Korner. (2014) The Sum of Many Parts: Potential Mechanisms for Improvement in Glucose Homeostasis After Bariatric Surgery. Current Diabetes Reports 14:5.
Crossref
Crossref
Daniel J. DruckerBernardo Yusta. (2014) Physiology and Pharmacology of the Enteroendocrine Hormone Glucagon-Like Peptide-2. Annual Review of Physiology 76:1, pages 561-583.
Crossref
Crossref
J. Luttikhold, F. M. de Ruijter, K. van Norren, M. Diamant, R. F. Witkamp, P. A. M. van Leeuwen & M. A. R. Vermeulen. (2013) Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients. Alimentary Pharmacology & Therapeutics 38:6, pages 573-583.
Crossref
Crossref
Caroline Bauchart-Thevret, Barbara Stoll, Nancy M. Benight, Oluyinka Olutoye, David Lazar & Douglas G. Burrin. (2013) Supplementing Monosodium Glutamate to Partial Enteral Nutrition Slows Gastric Emptying in Preterm Pigs. The Journal of Nutrition 143:5, pages 563-570.
Crossref
Crossref
Sara Baldassano, Antonella Amato, Francesco Cappello, Francesca Rappa & Flavia Mulè. (2013) Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. Journal of Endocrinology 217:1, pages 11-20.
Crossref
Crossref
P. Janssen, A. Rotondo, F. Mulé & J. Tack. (2012) Review article: a comparison of glucagon‐like peptides 1 and 2. Alimentary Pharmacology & Therapeutics 37:1, pages 18-36.
Crossref
Crossref
Charlotte X. Dong & Patricia L. Brubaker. (2012) Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nature Reviews Gastroenterology & Hepatology 9:12, pages 705-715.
Crossref
Crossref
Xinfu Guan, Xuemei ShiXiaojie LiBenny Chang, Yi WangDepei Li & Lawrence Chan. (2012) GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. American Journal of Physiology-Endocrinology and Metabolism 303:7, pages E853-E864.
Crossref
Crossref
Sara Baldassano, Anna Lisa Bellanca, Rosa Serio & Flavia Mulè. (2012) Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2. Journal of Endocrinology 213:3, pages 277-284.
Crossref
Crossref
Monica Mars, Annette Stafleu & Cees de Graaf. (2012) Use of satiety peptides in assessing the satiating capacity of foods. Physiology & Behavior 105:2, pages 483-488.
Crossref
Crossref
Peter J. Lyons & Lloyd D. Fricker. (2011) Carboxypeptidase O Is a Glycosylphosphatidylinositol-anchored Intestinal Peptidase with Acidic Amino Acid Specificity. Journal of Biological Chemistry 286:45, pages 39023-39032.
Crossref
Crossref
L. Cinci, M. S. Faussone‐Pellegrini, A. Rotondo, F. Mulè & M. G. Vannucchi. (2011) GLP‐2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterology & Motility 23:9.
Crossref
Crossref
Alessandra Rotondo, Antonella Amato, Sara Baldassano, Laura Lentini & Flavia Mulè. (2011) Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 32:8, pages 1587-1592.
Crossref
Crossref
Keisuke Suzuki, Channa N. Jayasena & Stephen R. Bloom. (2011) The Gut Hormones in Appetite Regulation. Journal of Obesity 2011, pages 1-10.
Crossref
Crossref
Antonella Amato, Alessandra Rotondo, Lorenzo Cinci, Sara Baldassano, Maria Giuliana Vannucchi & Flavia Mulè. (2010) Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon. American Journal of Physiology-Gastrointestinal and Liver Physiology 299:5, pages G1038-G1044.
Crossref
Crossref
Keisuke Suzuki, Katherine A Simpson, James S Minnion, Joyceline C Shillito & Stephen R Bloom. (2010) The role of gut hormones and the hypothalamus in appetite regulation. Endocrine Journal 57:5, pages 359-372.
Crossref
Crossref
Sara Baldassano, Sumei Liu, Mei-Hu Qu, Flavia Mulè & Jackie D. Wood. (2009) Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. American Journal of Physiology-Gastrointestinal and Liver Physiology 297:4, pages G800-G805.
Crossref
Crossref
V. Bucinskaite, T. Tolessa, J. Pedersen, B. Rydqvist, L. Zerihun, J. J. Holst & P. M. Hellström. (2009) Receptor‐mediated activation of gastric vagal afferents by glucagon‐like peptide‐1 in the rat. Neurogastroenterology & Motility 21:9, pages 978.
Crossref
Crossref
Katharina Wallis, Julian RF Walters & Simon Gabe. (2009) Short bowel syndrome: the role of GLP-2 on improving outcome. Current Opinion in Clinical Nutrition & Metabolic Care 12:5, pages 526-532.
Crossref
Crossref
Roger Yazbeck, Gordon S. Howarth & Catherine A. Abbott. (2009) Growth factor based therapies and intestinal disease: Is glucagon-like peptide-2 the new way forward?. Cytokine & Growth Factor Reviews 20:2, pages 175-184.
Crossref
Crossref
Antonella Amato, Sara Baldassano, Rosa Serio & Flavia Mulè. (2009) Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. American Journal of Physiology-Gastrointestinal and Liver Physiology 296:3, pages G678-G684.
Crossref
Crossref
Jens Juul Holst & Filip Krag Knop. 2008. The Metabolic Syndrome. The Metabolic Syndrome
233
254
.
Sean C. McDonagh, Jenny Lee, Angelo Izzo & Patricia L. Brubaker. (2007) Role of glial cell-line derived neurotropic factor family receptor α2 in the actions of the glucagon-like peptides on the murine intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:2, pages G461-G468.
Crossref
Crossref
K. WALLIS, J. R. F. WALTERS & A. FORBES. (2007) Review article: glucagon‐like peptide 2 – current applications and future directions. Alimentary Pharmacology & Therapeutics 25:4, pages 365-372.
Crossref
Crossref
A. C. Heijboer, H. Pijl, A. M. Van den Hoek, L. M. Havekes, J. A. Romijn & E. P. M. Corssmit. (2006) Gut–Brain Axis: Regulation of Glucose Metabolism. Journal of Neuroendocrinology 18:12, pages 883-894.
Crossref
Crossref
HIDEKI YOSHIKAWA, ICHIRO MIYATA & YOSHIKATSU ETO. (2006) Serum glucagon‐like peptide‐2 levels in neonates: Comparison between extremely low‐birthweight infants and normal‐term infants. Pediatrics International 48:5, pages 464-469.
Crossref
Crossref
Jennifer L. EstallDaniel J. Drucker. (2006) Glucagon-Like Peptide-2. Annual Review of Nutrition 26:1, pages 391-411.
Crossref
Crossref
Furio Brighenti, Luigi Benini, Daniele Del Rio, Cristina Casiraghi, Nicoletta Pellegrini, Francesca Scazzina, David JA Jenkins & Italo Vantini. (2006) Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. The American Journal of Clinical Nutrition 83:4, pages 817-822.
Crossref
Crossref
Juris J. Meier, Michael A. Nauck, Andrea Pott, Kai Heinze, Oliver Goetze, Kerem Bulut, Wolfgang E. Schmidt, Baptist Gallwitz & Jens J. Holst. (2006) Glucagon-Like Peptide 2 Stimulates Glucagon Secretion, Enhances Lipid Absorption, and Inhibits Gastric Acid Secretion in Humans. Gastroenterology 130:1, pages 44-54.
Crossref
Crossref
Jan Tack. (2005) Gastric motor and sensory function. Current Opinion in Gastroenterology 21:6, pages 665-672.
Crossref
Crossref
Patrice D. Cani, Audrey M. Neyrinck, Nicole Maton & Nathalie M. Delzenne. (2012) Oligofructose Promotes Satiety in Rats Fed a High‐Fat Diet: Involvement of Glucagon‐Like Peptide‐1. Obesity Research 13:6, pages 1000-1007.
Crossref
Crossref
Eric D Shin, Daniel J Drucker & Patricia L Brubaker. (2005) Glucagon-like peptide 2: an update. Current Opinion in Endocrinology & Diabetes 12:1, pages 63-71.
Crossref
Crossref